Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction
- PMID: 35331149
- PMCID: PMC8952226
- DOI: 10.1186/s12872-022-02566-0
Meta-analysis of the association between Apolipoprotein E polymorphism and risks of myocardial infarction
Abstract
Background: Myocardial infarction (MI) remains the leading cause of death and disability among cardiovascular diseases worldwide. Studies show that elevated low-density lipid protein cholesterol (LDL-C) levels confer the highest absolute risk of MI, and Apolipoprotein E (ApoE) is implicated in regulating levels of triglycerides (TGs), cholesterol, and LDL-C. Our study aimed to evaluate the association between APOE polymorphism and MI, and to provide evidence for the etiology of MI.
Methods: Case-control studies on the association between APOE polymorphisms and the risk of myocardial infarction were included by searching PubMed, Web of Science, and CNKI, and this meta-analysis was written in accordance with PRISMA guideline statement. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using either random-effects or fixed-effects models by R software.
Results: A total of 33 eligible articles involving 13,706 cases and 14,817 controls were finally selected. The pooled analysis based on the total eligible articles showed that the risk of MI was associated with ApoE epsilon 2 and epsilon 4 alleles. The results showed that patients with MI had a low frequency of the ε2 allele (OR 0.74, 95% CI 0.64-0.86) and a high frequency of the ε4 allele (OR 1.24, 95% CI 1.09-1.42).
Conclusions: APOE ε2-involved genotypes may be protective factors for MI; in contrast, ε4-involved genotypes (ε4/ε3 vs. ε3/ε3, and ε4/ε4 vs. ε3/ε3) may be risk factors for MI.
Keywords: Apolipoprotein E polymorphism; Meta-analysis; Myocardial infarction.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





References
-
- Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70–100 years: a contemporary primary prevention cohort. Lancet (London, England) 2020;396(10263):1644–1652. - PubMed
-
- Cahua-Pablo G, Cruz M, Moral-Hernández OD, Leyva-Vázquez MA, Antúnez-Ortiz DL, Cahua-Pablo JA, Alarcón-Romero Ldel C, Ortuño-Pineda C, Moreno-Godínez ME, Hernández-Sotelo D, et al. Elevated levels of LDL-C are associated with ApoE4 but not with the rs688 polymorphism in the LDLR gene. Clin Appl Thrombosis/Hemostasis. 2016;22(5):465–470. - PubMed
-
- Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol. 2015;5(4):1841–1875. - PubMed
-
- Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197–210. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous